Shimotsuga-gun, Japan

Hitomi Yamada

This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hitomi Yamada. Retrieved from https://idiyas.com/inventor/hitomi-yamada-xoc625xc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hitomi Yamada

Introduction: Hitomi Yamada is a prominent inventor based in Shimotsuga-gun, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents: Hitomi Yamada holds a patent for a 15-PGDH inhibitor. This invention is a compound represented by a general formula (1) or a pharmacologically acceptable salt thereof, designed for inhibiting 15-PDGH. This innovation has the potential to play a crucial role in therapeutic applications.

Career Highlights: Yamada's career is marked by her dedication to research and development in the pharmaceutical industry. She is currently associated with Kyorin Pharmaceutical Co., Ltd., where she continues to explore new avenues for drug development and innovation.

Collaborations: Throughout her career, Hitomi Yamada has collaborated with notable colleagues, including Shigeki Seto and Yoshifumi Saito. These partnerships have fostered a collaborative environment that enhances the research process and leads to groundbreaking discoveries.

Conclusion: Hitomi Yamada's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in medicine. Her work on the 15-PGDH inhibitor highlights her role as a leading inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…